Key Points
- Insider sale: American Well insider Phyllis Gotlib sold 3,573 shares on June 1 at an average price of $9.74, totaling about $34,801. After the sale, she still held 159,431 shares.
- Recent company performance: AMWL last closed/opened around $8.35, with the stock trading near its 52-week high of $9.96. The company reported a smaller-than-expected quarterly loss and revenue above analyst estimates.
- Wall Street view: Analysts currently rate American Well a Hold overall, with a consensus price target of $7.13. Recent target changes have been mixed, reflecting cautious sentiment toward the telehealth company.
American Well Corporation (NYSE:AMWL - Get Free Report) insider Phyllis Gotlib sold 3,573 shares of the firm's stock in a transaction on Monday, June 1st. The shares were sold at an average price of $9.74, for a total value of $34,801.02. Following the completion of the transaction, the insider owned 159,431 shares in the company, valued at $1,552,857.94. The trade was a 2.19% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.
Phyllis Gotlib also recently made the following trade(s):
- On Wednesday, April 1st, Phyllis Gotlib sold 3,706 shares of American Well stock. The shares were sold at an average price of $5.30, for a total value of $19,641.80.
American Well Stock Performance
Shares of AMWL stock opened at $8.35 on Thursday. The stock's fifty day moving average is $6.80 and its two-hundred day moving average is $5.51. The firm has a market capitalization of $138.21 million, a P/E ratio of -1.54 and a beta of 1.69. American Well Corporation has a fifty-two week low of $3.71 and a fifty-two week high of $9.96.
American Well (NYSE:AMWL - Get Free Report) last announced its quarterly earnings data on Tuesday, May 5th. The company reported ($0.66) earnings per share for the quarter, beating analysts' consensus estimates of ($0.77) by $0.11. American Well had a negative return on equity of 32.11% and a negative net margin of 37.02%.The company had revenue of $54.88 million for the quarter, compared to analyst estimates of $51.54 million. On average, equities analysts forecast that American Well Corporation will post -2.68 earnings per share for the current year.
Wall Street Analyst Weigh In
Several research analysts have recently commented on the company. Stifel Nicolaus reduced their price target on American Well from $6.00 to $5.00 and set a "hold" rating on the stock in a report on Friday, February 13th. Morgan Stanley lifted their price target on American Well from $6.00 to $6.50 and gave the stock an "equal weight" rating in a report on Wednesday, May 6th. Wall Street Zen upgraded American Well from a "sell" rating to a "hold" rating in a report on Sunday, March 22nd. Finally, TD Cowen lifted their price target on American Well from $5.00 to $8.00 and gave the stock a "hold" rating in a report on Wednesday, May 6th. One equities research analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $7.13.
Read Our Latest Report on American Well
Institutional Trading of American Well
Institutional investors and hedge funds have recently bought and sold shares of the stock. Headlands Technologies LLC purchased a new stake in American Well in the 2nd quarter valued at about $39,000. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in American Well in the 3rd quarter valued at about $62,000. Engineers Gate Manager LP purchased a new stake in American Well in the 2nd quarter valued at about $101,000. Prelude Capital Management LLC purchased a new stake in American Well in the 3rd quarter valued at about $86,000. Finally, JPMorgan Chase & Co. raised its holdings in American Well by 16.5% in the 2nd quarter. JPMorgan Chase & Co. now owns 14,720 shares of the company's stock valued at $131,000 after buying an additional 2,081 shares during the period. 56.05% of the stock is currently owned by hedge funds and other institutional investors.
American Well Company Profile
(
Get Free Report)
American Well, operating under the trade name Amwell, is a Boston-based digital health company that develops and delivers telehealth solutions to healthcare providers, payers, employers and patients. Through its cloud-based platform, the company enables secure virtual visits, remote patient monitoring and integrated care coordination across a range of medical disciplines, including primary care, behavioral health, chronic disease management and urgent care.
The company's core offering, the Amwell Telehealth Platform, facilitates live video consultations, asynchronous messaging, e-prescribing and electronic health record integration.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
